These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 29105055)

  • 1. The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.
    Demarest ST; Shellhaas RA; Gaillard WD; Keator C; Nickels KC; Hussain SA; Loddenkemper T; Patel AD; Saneto RP; Wirrell E; Sánchez Fernández I; Chu CJ; Grinspan Z; Wusthoff CJ; Joshi S; Mohamed IS; Stafstrom CE; Stack CV; Yozawitz E; Bluvstein JS; Singh RK; Knupp KG;
    Epilepsia; 2017 Dec; 58(12):2098-2103. PubMed ID: 29105055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to treatment in a prospective national infantile spasms cohort.
    Knupp KG; Coryell J; Nickels KC; Ryan N; Leister E; Loddenkemper T; Grinspan Z; Hartman AL; Kossoff EH; Gaillard WD; Mytinger JR; Joshi S; Shellhaas RA; Sullivan J; Dlugos D; Hamikawa L; Berg AT; Millichap J; Nordli DR; Wirrell E;
    Ann Neurol; 2016 Mar; 79(3):475-84. PubMed ID: 26704170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Time to Clinical Remission With Sustained Resolution in Children With New-Onset Infantile Spasms.
    Yuskaitis CJ; Mytinger JR; Baumer FM; Zhang B; Liu S; Samanta D; Hussain SA; Yozawitz EG; Keator CG; Joshi C; Singh RK; Bhatia S; Bhalla S; Shellhaas R; Harini C;
    Neurology; 2022 Nov; 99(22):e2494-e2503. PubMed ID: 36038267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
    Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
    J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.
    Knupp KG; Leister E; Coryell J; Nickels KC; Ryan N; Juarez-Colunga E; Gaillard WD; Mytinger JR; Berg AT; Millichap J; Nordli DR; Joshi S; Shellhaas RA; Loddenkemper T; Dlugos D; Wirrell E; Sullivan J; Hartman AL; Kossoff EH; Grinspan ZM; Hamikawa L;
    Epilepsia; 2016 Nov; 57(11):1834-1842. PubMed ID: 27615012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
    Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
    Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
    O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin for infantile spasms.
    Pesaturo KA; Spooner LM; Belliveau P
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first-line therapies.
    Olson HE; Demarest S; Pestana-Knight E; Moosa AN; Zhang X; Pérez-Pérez JR; Weisenberg J; O'Connor Prange E; Marsh ED; Rajaraman RR; Suter B; Katyayan A; Haviland I; Daniels C; Zhang B; Greene C; DeLeo M; Swanson L; Love-Nichols J; Benke T; Harini C; Poduri A
    Epilepsia; 2023 Jul; 64(7):1821-1832. PubMed ID: 37114835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental and epilepsy outcomes of patients with infantile spasms treated in a tertiary care center.
    Bashiri FA; Al-Sehemi MA; Hamad MH; Alshammari NR; Aljumah MA; Kentab A; Salih MA
    Neurosciences (Riyadh); 2021 Jan; 26(1):21-25. PubMed ID: 33530039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of infantile spasms.
    Hancock EC; Osborne JP; Edwards SW
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001770. PubMed ID: 23740534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
    Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE
    Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocorticotropic hormone versus prednisolone in the treatment of infantile spasms post vigabatrin failure.
    Jones K; Snead OC; Boyd J; Go C
    J Child Neurol; 2015 Apr; 30(5):595-600. PubMed ID: 24965788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of vigabatrin in Japanese patients with infantile spasms: Primary short-term study and extension study.
    Ohtsuka Y
    Epilepsy Behav; 2018 Jan; 78():134-141. PubMed ID: 29190579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile Spasms-Have We Made Progress?
    Kelley SA; Knupp KG
    Curr Neurol Neurosci Rep; 2018 Apr; 18(5):27. PubMed ID: 29671077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.
    Mackay MT; Weiss SK; Adams-Webber T; Ashwal S; Stephens D; Ballaban-Gill K; Baram TZ; Duchowny M; Hirtz D; Pellock JM; Shields WD; Shinnar S; Wyllie E; Snead OC; ;
    Neurology; 2004 May; 62(10):1668-81. PubMed ID: 15159460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
    Ibrahim S; Gulab S; Ishaque S; Saleem T
    BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study.
    O'Callaghan FJ; Lux AL; Darke K; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; Verity CM; Osborne JP
    Epilepsia; 2011 Jul; 52(7):1359-64. PubMed ID: 21668442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.